{"created_at":"Fri Jun 20 00:03:29 +0000 2014","id":479776515048357888,"id_str":"479776515048357888","text":"Subscribers saw our Penny Stock Picks gain over 4,000% this year! Subscribe Today: http:\/\/t.co\/4wK9alr02J $ACT $VRX $ABBV","source":"\u003ca href=\"http:\/\/twitter.com\" rel=\"nofollow\"\u003eTwitter Web Client\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":2447967798,"id_str":"2447967798","name":"Stockaholics","screen_name":"Stockaholics","location":"","url":null,"description":"Read our full disclaimer before looking at any of our tweets! Full Disclaimer:  http:\/\/tinyurl.com\/mcsbvzz","protected":false,"verified":false,"followers_count":16628,"friends_count":1,"listed_count":11,"favourites_count":13,"statuses_count":67312,"created_at":"Wed Apr 16 20:27:43 +0000 2014","utc_offset":null,"time_zone":null,"geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"0084B4","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/456529846420525056\/wLucrlXI_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/456529846420525056\/wLucrlXI_normal.jpeg","default_profile":true,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[{"url":"http:\/\/t.co\/4wK9alr02J","expanded_url":"http:\/\/www.pennystockdream.com\/blog\/within-4-months-subscribers-to-our-penny-stock-newsletter-platform-saw-our-alerts-gain-more","display_url":"pennystockdream.com\/blog\/within-4-\u2026","indices":[83,105]}],"user_mentions":[],"symbols":[{"text":"ACT","indices":[106,110]},{"text":"VRX","indices":[111,115]},{"text":"ABBV","indices":[116,121]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en"}
{"created_at":"Thu Jun 19 23:49:01 +0000 2014","id":479772874396295168,"id_str":"479772874396295168","text":"$ABBV: Exclusive - AbbVie approaches Shire about possible takeover: sources http:\/\/t.co\/xaDSn59aoj","source":"\u003ca href=\"http:\/\/lovelystocks.com\" rel=\"nofollow\"\u003ees9evCqbXg9\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":2329478684,"id_str":"2329478684","name":"PlaceTrader","screen_name":"PlaceTrader","location":"","url":null,"description":null,"protected":false,"verified":false,"followers_count":95,"friends_count":0,"listed_count":9,"favourites_count":0,"statuses_count":78466,"created_at":"Wed Feb 05 23:09:41 +0000 2014","utc_offset":-14400,"time_zone":"Eastern Time (US & Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"0084B4","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/453874647465877504\/wJ9ClnGj_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/453874647465877504\/wJ9ClnGj_normal.jpeg","default_profile":true,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[{"url":"http:\/\/t.co\/xaDSn59aoj","expanded_url":"http:\/\/stockratingreport.com\/i.php?http:\/\/www.reuters.com\/article\/2014\/06\/19\/us-shire-abbvie-exclusive-idUSKBN0EU2Q020140619?feedType=RSS&t6t=ABBV","display_url":"stockratingreport.com\/i.php?http:\/\/w\u2026","indices":[76,98]}],"user_mentions":[],"symbols":[{"text":"ABBV","indices":[0,5]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en"}
{"created_at":"Fri Jun 20 12:53:19 +0000 2014","id":479970249945915393,"id_str":"479970249945915393","text":"RT @OpenOutcrier: $SPHG Hearing $ABBV considering a higher offer for Shire","source":"\u003ca href=\"https:\/\/about.twitter.com\/products\/tweetdeck\" rel=\"nofollow\"\u003eTweetDeck\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":1311004524,"id_str":"1311004524","name":"david jelly","screen_name":"davidjelly2","location":"","url":null,"description":null,"protected":false,"verified":false,"followers_count":10,"friends_count":16,"listed_count":0,"favourites_count":0,"statuses_count":1457,"created_at":"Thu Mar 28 15:52:31 +0000 2013","utc_offset":null,"time_zone":null,"geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"0084B4","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/3443030001\/982c466a4c511c4c77d3330e853df505_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/3443030001\/982c466a4c511c4c77d3330e853df505_normal.jpeg","default_profile":true,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweeted_status":{"created_at":"Fri Jun 20 12:52:38 +0000 2014","id":479970077060509696,"id_str":"479970077060509696","text":"$SPHG Hearing $ABBV considering a higher offer for Shire","source":"\u003ca href=\"http:\/\/twitter.com\" rel=\"nofollow\"\u003eTwitter Web Client\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":2334614718,"id_str":"2334614718","name":"Open Outcrier","screen_name":"OpenOutcrier","location":"Chicago, IL","url":null,"description":"Real-time option trading headlines, breaking news, rumors and strategy.  Nothing we post constitutes investment advice; we may have positions in mentioned names","protected":false,"verified":false,"followers_count":1627,"friends_count":171,"listed_count":62,"favourites_count":151,"statuses_count":5220,"created_at":"Sun Feb 09 05:53:38 +0000 2014","utc_offset":-18000,"time_zone":"Central Time (US & Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"0084B4","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/440919387902455808\/CAVDa35d_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/440919387902455808\/CAVDa35d_normal.jpeg","profile_banner_url":"https:\/\/pbs.twimg.com\/profile_banners\/2334614718\/1402501896","default_profile":true,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":2,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[],"user_mentions":[],"symbols":[{"text":"SPHG","indices":[0,5]},{"text":"ABBV","indices":[14,19]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en"},"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[],"user_mentions":[{"screen_name":"OpenOutcrier","name":"Open Outcrier","id":2334614718,"id_str":"2334614718","indices":[3,16]}],"symbols":[{"text":"SPHG","indices":[18,23]},{"text":"ABBV","indices":[32,37]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en"}
{"created_at":"Fri Jun 20 10:10:38 +0000 2014","id":479929309331603456,"id_str":"479929309331603456","text":"AbbVie says Shire has spurned three buyout offers, won't rule out new bid. http:\/\/t.co\/fRi91VqRJy by @JohnCFierce $ABBV $SHPG","source":"\u003ca href=\"https:\/\/about.twitter.com\/products\/tweetdeck\" rel=\"nofollow\"\u003eTweetDeck\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":18294197,"id_str":"18294197","name":"FierceBiotech","screen_name":"FierceBiotech","location":"Washington, DC","url":"http:\/\/FierceBiotech.com","description":"Tweets by the Fierce Life Sciences editorial team. Subscribe to our daily email newsletter at http:\/\/www.fiercebiotech.com\/offer\/signup","protected":false,"verified":false,"followers_count":31157,"friends_count":474,"listed_count":1074,"favourites_count":6,"statuses_count":14290,"created_at":"Sun Dec 21 22:21:58 +0000 2008","utc_offset":-14400,"time_zone":"Eastern Time (US & Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"15184C","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"DB5E1F","profile_sidebar_border_color":"FFFFFF","profile_sidebar_fill_color":"EBEFC3","profile_text_color":"333333","profile_use_background_image":false,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/2579189363\/5zktggp40a8nfj341ed2_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/2579189363\/5zktggp40a8nfj341ed2_normal.jpeg","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[{"url":"http:\/\/t.co\/fRi91VqRJy","expanded_url":"http:\/\/www.fiercebiotech.com\/story\/abbvie-says-shire-has-rejected-three-buyout-offers-wont-rule-out-new-bid\/2014-06-20","display_url":"fiercebiotech.com\/story\/abbvie-s\u2026","indices":[75,97]}],"user_mentions":[{"screen_name":"JohnCFierce","name":"John Carroll","id":102754598,"id_str":"102754598","indices":[101,113]}],"symbols":[{"text":"ABBV","indices":[114,119]},{"text":"SHPG","indices":[120,125]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en"}
{"created_at":"Fri Jun 20 16:12:10 +0000 2014","id":480020292186951680,"id_str":"480020292186951680","text":"AbbVie's outperform rating reiterated at Credit Suisse. $60.00 PT. http:\/\/t.co\/y32BeUuAun $ABBV #ABBV","source":"\u003ca href=\"http:\/\/ifttt.com\" rel=\"nofollow\"\u003eIFTTT\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":68559732,"id_str":"68559732","name":"US Consumer News","screen_name":"ConsumerFeed","location":"Sioux Falls, SD","url":"http:\/\/www.americanconsumernews.com","description":"News for Consumers in a Changing World","protected":false,"verified":false,"followers_count":3946,"friends_count":2884,"listed_count":167,"favourites_count":0,"statuses_count":57653,"created_at":"Tue Aug 25 00:39:44 +0000 2009","utc_offset":-18000,"time_zone":"Central Time (US & Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"FFF04D","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme19\/bg.gif","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme19\/bg.gif","profile_background_tile":false,"profile_link_color":"0099CC","profile_sidebar_border_color":"FFF8AD","profile_sidebar_fill_color":"F6FFD1","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/379977873\/msn_normal.jpg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/379977873\/msn_normal.jpg","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[{"text":"ABBV","indices":[96,101]}],"trends":[],"urls":[{"url":"http:\/\/t.co\/y32BeUuAun","expanded_url":"http:\/\/ift.tt\/1rg7Wtr","display_url":"ift.tt\/1rg7Wtr","indices":[67,89]}],"user_mentions":[],"symbols":[{"text":"ABBV","indices":[90,95]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en"}
{"created_at":"Fri Jun 20 13:28:12 +0000 2014","id":479979028624203776,"id_str":"479979028624203776","text":"RT @SeekingAlpha: Fire Up The Immuno-Oncology Powerhouses: John McCamant http:\/\/t.co\/mBdvMy0wMa $ABBV $ANTH $INCY $NVAX $PCYC","source":"\u003ca href=\"http:\/\/twitter.com\/download\/android\" rel=\"nofollow\"\u003eTwitter for Android\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":53359947,"id_str":"53359947","name":"Berlinbeing","screen_name":"berlinbeing","location":"Berlin, Germany","url":null,"description":"Be fearful when others are greedy, and be greedy when others are fearful.","protected":false,"verified":false,"followers_count":121,"friends_count":76,"listed_count":2,"favourites_count":18,"statuses_count":1047,"created_at":"Fri Jul 03 11:22:47 +0000 2009","utc_offset":7200,"time_zone":"Berlin","geo_enabled":false,"lang":"de","contributors_enabled":false,"is_translator":false,"profile_background_color":"022330","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme15\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme15\/bg.png","profile_background_tile":false,"profile_link_color":"0084B4","profile_sidebar_border_color":"A8C7F7","profile_sidebar_fill_color":"C0DFEC","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/423156575432228864\/-agVipm4_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/423156575432228864\/-agVipm4_normal.jpeg","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweeted_status":{"created_at":"Thu Jun 19 21:39:41 +0000 2014","id":479740326345588736,"id_str":"479740326345588736","text":"Fire Up The Immuno-Oncology Powerhouses: John McCamant http:\/\/t.co\/mBdvMy0wMa $ABBV $ANTH $INCY $NVAX $PCYC","source":"\u003ca href=\"http:\/\/seekingalpha.com\" rel=\"nofollow\"\u003eSeeking Alpha\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":23059499,"id_str":"23059499","name":"Seeking Alpha","screen_name":"SeekingAlpha","location":"","url":"http:\/\/SeekingAlpha.com","description":"Seeking Alpha is the #1 crowd sourced equity research platform. Follow analysis by investors for investors from Seeking Alpha. Sign up at http:\/\/t.co\/q8sAeDrsnR","protected":false,"verified":false,"followers_count":57852,"friends_count":9,"listed_count":2061,"favourites_count":16,"statuses_count":243911,"created_at":"Fri Mar 06 12:52:56 +0000 2009","utc_offset":-14400,"time_zone":"Eastern Time (US & Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"D9D9D9","profile_background_image_url":"http:\/\/pbs.twimg.com\/profile_background_images\/436400133916225536\/dxS1wkvd.png","profile_background_image_url_https":"https:\/\/pbs.twimg.com\/profile_background_images\/436400133916225536\/dxS1wkvd.png","profile_background_tile":false,"profile_link_color":"4A0C0D","profile_sidebar_border_color":"FFFFFF","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/460405071453249536\/hNv3Xbww_normal.png","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/460405071453249536\/hNv3Xbww_normal.png","profile_banner_url":"https:\/\/pbs.twimg.com\/profile_banners\/23059499\/1398763809","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":2,"favorite_count":1,"entities":{"hashtags":[],"trends":[],"urls":[{"url":"http:\/\/t.co\/mBdvMy0wMa","expanded_url":"http:\/\/seekingalpha.com\/article\/2278023-fire-up-the-immuno-oncology-powerhouses-john-mccamant?source=feed_f","display_url":"seekingalpha.com\/article\/227802\u2026","indices":[55,77]}],"user_mentions":[],"symbols":[{"text":"ABBV","indices":[78,83]},{"text":"ANTH","indices":[84,89]},{"text":"INCY","indices":[90,95]},{"text":"NVAX","indices":[96,101]},{"text":"PCYC","indices":[102,107]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en"},"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[{"url":"http:\/\/t.co\/mBdvMy0wMa","expanded_url":"http:\/\/seekingalpha.com\/article\/2278023-fire-up-the-immuno-oncology-powerhouses-john-mccamant?source=feed_f","display_url":"seekingalpha.com\/article\/227802\u2026","indices":[73,95]}],"user_mentions":[{"screen_name":"SeekingAlpha","name":"Seeking Alpha","id":23059499,"id_str":"23059499","indices":[3,16]}],"symbols":[{"text":"ABBV","indices":[96,101]},{"text":"ANTH","indices":[102,107]},{"text":"INCY","indices":[108,113]},{"text":"NVAX","indices":[114,119]},{"text":"PCYC","indices":[120,125]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en"}
{"created_at":"Fri Jun 20 12:33:14 +0000 2014","id":479965195817996288,"id_str":"479965195817996288","text":"Drug maker Shire rejects offer from AbbVie.. http:\/\/t.co\/N6szm4JHRX $ABBV #biotech #stocks","source":"\u003ca href=\"http:\/\/12stocks.com\/biotech\" rel=\"nofollow\"\u003eBiotechTweets\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":2451406717,"id_str":"2451406717","name":"12Stocks.com Biotech","screen_name":"Stocks_Biotech","location":"Orlando, FL","url":"http:\/\/12Stocks.com\/biotech","description":"New! Just Launched ! Everything Biotech. Most Comprehensive Coverage Of Biotechnology Stocks and ETFs. Get Top Biotech Stocks News, Trends & More @","protected":false,"verified":false,"followers_count":110,"friends_count":46,"listed_count":2,"favourites_count":0,"statuses_count":3192,"created_at":"Fri Apr 18 13:54:28 +0000 2014","utc_offset":-10800,"time_zone":"Atlantic Time (Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"0084B4","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/458888012349177857\/1OMoVCmJ_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/458888012349177857\/1OMoVCmJ_normal.jpeg","default_profile":true,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[{"text":"biotech","indices":[74,82]},{"text":"stocks","indices":[83,90]}],"trends":[],"urls":[{"url":"http:\/\/t.co\/N6szm4JHRX","expanded_url":"http:\/\/sg.finance.yahoo.com\/news\/drug-maker-shire-rejects-offer-110655952--finance.html","display_url":"sg.finance.yahoo.com\/news\/drug-make\u2026","indices":[45,67]}],"user_mentions":[],"symbols":[{"text":"ABBV","indices":[68,73]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en"}
{"created_at":"Fri Jun 20 11:40:12 +0000 2014","id":479951849551036417,"id_str":"479951849551036417","text":"RT @fwpharma: ICYMI: AbbVie says offer to acquire Shire for around $46 billion rejected http:\/\/t.co\/Szk3LzwJgi $ABBV $SHP #pharma","source":"\u003ca href=\"http:\/\/twitter.com\/download\/iphone\" rel=\"nofollow\"\u003eTwitter for iPhone\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":186603587,"id_str":"186603587","name":"mat  war","screen_name":"Bedown7","location":"","url":null,"description":null,"protected":false,"verified":false,"followers_count":204,"friends_count":255,"listed_count":2,"favourites_count":12,"statuses_count":6170,"created_at":"Fri Sep 03 22:18:42 +0000 2010","utc_offset":null,"time_zone":null,"geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"0084B4","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/3353978302\/ea8148397dcfd4b33bda348fc7ce6dc7_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/3353978302\/ea8148397dcfd4b33bda348fc7ce6dc7_normal.jpeg","default_profile":true,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweeted_status":{"created_at":"Fri Jun 20 11:19:53 +0000 2014","id":479946734769291264,"id_str":"479946734769291264","text":"ICYMI: AbbVie says offer to acquire Shire for around $46 billion rejected http:\/\/t.co\/Szk3LzwJgi $ABBV $SHP #pharma","source":"\u003ca href=\"https:\/\/about.twitter.com\/products\/tweetdeck\" rel=\"nofollow\"\u003eTweetDeck\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":35789155,"id_str":"35789155","name":"FirstWord Pharma","screen_name":"fwpharma","location":"","url":"http:\/\/firstwordpharma.com","description":"The latest global pharma news, insights, analysis, and views providing you with an information edge.  FirstWord Pharma. Where people who know first, go first.","protected":false,"verified":false,"followers_count":19296,"friends_count":407,"listed_count":533,"favourites_count":9,"statuses_count":15937,"created_at":"Mon Apr 27 16:44:14 +0000 2009","utc_offset":-14400,"time_zone":"Eastern Time (US & Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"305F8E","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"0084B4","profile_sidebar_border_color":"666666","profile_sidebar_fill_color":"EFEFEF","profile_text_color":"333333","profile_use_background_image":false,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/1811310207\/FW_Pharma_Twitter_normal.jpg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/1811310207\/FW_Pharma_Twitter_normal.jpg","profile_banner_url":"https:\/\/pbs.twimg.com\/profile_banners\/35789155\/1403125084","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":4,"favorite_count":0,"entities":{"hashtags":[{"text":"pharma","indices":[108,115]}],"trends":[],"urls":[{"url":"http:\/\/t.co\/Szk3LzwJgi","expanded_url":"http:\/\/bit.ly\/1lOZfkt","display_url":"bit.ly\/1lOZfkt","indices":[74,96]}],"user_mentions":[],"symbols":[{"text":"ABBV","indices":[97,102]},{"text":"SHP","indices":[103,107]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en"},"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[{"text":"pharma","indices":[122,129]}],"trends":[],"urls":[{"url":"http:\/\/t.co\/Szk3LzwJgi","expanded_url":"http:\/\/bit.ly\/1lOZfkt","display_url":"bit.ly\/1lOZfkt","indices":[88,110]}],"user_mentions":[{"screen_name":"fwpharma","name":"FirstWord Pharma","id":35789155,"id_str":"35789155","indices":[3,12]}],"symbols":[{"text":"ABBV","indices":[111,116]},{"text":"SHP","indices":[117,121]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en"}
{"created_at":"Fri Jun 20 14:59:36 +0000 2014","id":480002030195703809,"id_str":"480002030195703809","text":"RT @OpeningBellFBN: @EliLillyCo John Lechleiter tells @MariaBartiromo tax inversion will not drive deals for the company $ABBV $PFE","source":"\u003ca href=\"http:\/\/twitter.com\" rel=\"nofollow\"\u003eTwitter Web Client\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":1039081430,"id_str":"1039081430","name":"Zubeyr Kamil A\u00e7\u0131ksar","screen_name":"9A_ZKA","location":"Istanbul","url":null,"description":"He likes reading articles, learning new languages, making business and communicating with the people.. His role model is Jeff Hoffman..","protected":false,"verified":false,"followers_count":481,"friends_count":1971,"listed_count":3,"favourites_count":182,"statuses_count":5254,"created_at":"Thu Dec 27 07:44:46 +0000 2012","utc_offset":10800,"time_zone":"Athens","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"EDECE9","profile_background_image_url":"http:\/\/pbs.twimg.com\/profile_background_images\/750688069\/18fdc4efe2a5488d6c7b21ed69c1daeb.jpeg","profile_background_image_url_https":"https:\/\/pbs.twimg.com\/profile_background_images\/750688069\/18fdc4efe2a5488d6c7b21ed69c1daeb.jpeg","profile_background_tile":true,"profile_link_color":"088253","profile_sidebar_border_color":"FFFFFF","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/378800000440866892\/98fe7c81d78b78037c9672c420ef5fad_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/378800000440866892\/98fe7c81d78b78037c9672c420ef5fad_normal.jpeg","profile_banner_url":"https:\/\/pbs.twimg.com\/profile_banners\/1039081430\/1356817141","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweeted_status":{"created_at":"Fri Jun 20 14:52:26 +0000 2014","id":480000226833747968,"id_str":"480000226833747968","text":"@EliLillyCo John Lechleiter tells @MariaBartiromo tax inversion will not drive deals for the company $ABBV $PFE","source":"\u003ca href=\"http:\/\/twitter.com\" rel=\"nofollow\"\u003eTwitter Web Client\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":1169906335,"in_reply_to_user_id_str":"1169906335","in_reply_to_screen_name":"EliLillyCo","user":{"id":2330590446,"id_str":"2330590446","name":"Opening Bell FBN","screen_name":"OpeningBellFBN","location":"","url":"http:\/\/www.foxbusiness.com\/on-air\/opening-bell\/index.html","description":"Join Maria Bartiromo every weekday from 9-11 AM only on Fox Business.","protected":false,"verified":true,"followers_count":2276,"friends_count":64,"listed_count":52,"favourites_count":4,"statuses_count":571,"created_at":"Thu Feb 06 17:15:29 +0000 2014","utc_offset":null,"time_zone":null,"geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"0B283A","profile_background_image_url":"http:\/\/pbs.twimg.com\/profile_background_images\/433642236719267841\/WVf1O2L5.png","profile_background_image_url_https":"https:\/\/pbs.twimg.com\/profile_background_images\/433642236719267841\/WVf1O2L5.png","profile_background_tile":false,"profile_link_color":"0084B4","profile_sidebar_border_color":"FFFFFF","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/433641223039877120\/3J0d2aTk_normal.png","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/433641223039877120\/3J0d2aTk_normal.png","profile_banner_url":"https:\/\/pbs.twimg.com\/profile_banners\/2330590446\/1392223111","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":3,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[],"user_mentions":[{"screen_name":"EliLillyCo","name":"Eli Lilly and Co","id":1169906335,"id_str":"1169906335","indices":[0,11]},{"screen_name":"MariaBartiromo","name":"Maria Bartiromo ","id":208155240,"id_str":"208155240","indices":[34,49]}],"symbols":[{"text":"ABBV","indices":[101,106]},{"text":"PFE","indices":[107,111]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en"},"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[],"user_mentions":[{"screen_name":"OpeningBellFBN","name":"Opening Bell FBN","id":2330590446,"id_str":"2330590446","indices":[3,18]},{"screen_name":"EliLillyCo","name":"Eli Lilly and Co","id":1169906335,"id_str":"1169906335","indices":[20,31]},{"screen_name":"MariaBartiromo","name":"Maria Bartiromo ","id":208155240,"id_str":"208155240","indices":[54,69]}],"symbols":[{"text":"ABBV","indices":[121,126]},{"text":"PFE","indices":[127,131]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en"}
{"created_at":"Fri Jun 20 08:06:15 +0000 2014","id":479898007270604800,"id_str":"479898007270604800","text":"$ABBV - Shire rejects AbbVie takeover approaches -&gt; http:\/\/t.co\/EqRZDUwWkH #stock #stocks #stockaction","source":"\u003ca href=\"http:\/\/www.pennystocks24.com\" rel=\"nofollow\"\u003ePennystocks24.com\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":300706809,"id_str":"300706809","name":"StockNews24","screen_name":"Pennystocks24","location":"","url":"http:\/\/stocknews.net","description":"Daily Stock News","protected":false,"verified":false,"followers_count":18610,"friends_count":7,"listed_count":119,"favourites_count":5,"statuses_count":215333,"created_at":"Wed May 18 06:52:58 +0000 2011","utc_offset":-14400,"time_zone":"Eastern Time (US & Canada)","geo_enabled":false,"lang":"de","contributors_enabled":false,"is_translator":false,"profile_background_color":"022330","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme15\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme15\/bg.png","profile_background_tile":false,"profile_link_color":"0084B4","profile_sidebar_border_color":"A8C7F7","profile_sidebar_fill_color":"C0DFEC","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/378800000724847960\/0b9dc32c2bf3075387670edebf26f5f6_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/378800000724847960\/0b9dc32c2bf3075387670edebf26f5f6_normal.jpeg","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[{"text":"stock","indices":[78,84]},{"text":"stocks","indices":[85,92]},{"text":"stockaction","indices":[93,105]}],"trends":[],"urls":[{"url":"http:\/\/t.co\/EqRZDUwWkH","expanded_url":"http:\/\/stock-news.net\/1249327","display_url":"stock-news.net\/1249327","indices":[55,77]}],"user_mentions":[],"symbols":[{"text":"ABBV","indices":[0,5]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en"}
{"created_at":"Fri Jun 20 08:06:24 +0000 2014","id":479898045002579969,"id_str":"479898045002579969","text":"$ABBV - Shire props up European shares on bid hopes -&gt; http:\/\/t.co\/qaGZJuCWjc #stock #stocks #stockaction","source":"\u003ca href=\"http:\/\/www.pennystocks24.com\" rel=\"nofollow\"\u003ePennystocks24.com\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":300706809,"id_str":"300706809","name":"StockNews24","screen_name":"Pennystocks24","location":"","url":"http:\/\/stocknews.net","description":"Daily Stock News","protected":false,"verified":false,"followers_count":18610,"friends_count":7,"listed_count":119,"favourites_count":5,"statuses_count":215335,"created_at":"Wed May 18 06:52:58 +0000 2011","utc_offset":-14400,"time_zone":"Eastern Time (US & Canada)","geo_enabled":false,"lang":"de","contributors_enabled":false,"is_translator":false,"profile_background_color":"022330","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme15\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme15\/bg.png","profile_background_tile":false,"profile_link_color":"0084B4","profile_sidebar_border_color":"A8C7F7","profile_sidebar_fill_color":"C0DFEC","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/378800000724847960\/0b9dc32c2bf3075387670edebf26f5f6_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/378800000724847960\/0b9dc32c2bf3075387670edebf26f5f6_normal.jpeg","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[{"text":"stock","indices":[81,87]},{"text":"stocks","indices":[88,95]},{"text":"stockaction","indices":[96,108]}],"trends":[],"urls":[{"url":"http:\/\/t.co\/qaGZJuCWjc","expanded_url":"http:\/\/stock-news.net\/1249326","display_url":"stock-news.net\/1249326","indices":[58,80]}],"user_mentions":[],"symbols":[{"text":"ABBV","indices":[0,5]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en"}
{"created_at":"Fri Jun 20 14:41:19 +0000 2014","id":479997429031264257,"id_str":"479997429031264257","text":"$ABBV critics 'straw man' argument: Humira patents begin expiry in '16, so obviously Humira revenues decline significantly... false","source":"\u003ca href=\"http:\/\/twitter.com\" rel=\"nofollow\"\u003eTwitter Web Client\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":1166764590,"id_str":"1166764590","name":"Bo Czernyk","screen_name":"MDsearchlight","location":"NYC & Sarasota","url":"http:\/\/linkedin.com\/in\/bosearchlight","description":"Executive search in Healthcare, Lifesciences & Finance. Advocate for hepC treatment & patient care policy.","protected":false,"verified":false,"followers_count":305,"friends_count":394,"listed_count":10,"favourites_count":167,"statuses_count":2489,"created_at":"Sun Feb 10 19:22:49 +0000 2013","utc_offset":-14400,"time_zone":"Eastern Time (US & Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"1E155C","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/378800000716561710\/e2a1210be0c61c2409928c560e95ecb3_normal.png","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/378800000716561710\/e2a1210be0c61c2409928c560e95ecb3_normal.png","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[],"user_mentions":[],"symbols":[{"text":"ABBV","indices":[0,5]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en"}
